Ex Vivo Therapeutic Assessments on Patient Derived Organotypic Tumor Spheroids

  • Xsphera procures qualified patient tumor samples for the study from its clinical site network
  • Immune profiling is performed on each patient sample
  • Post-treatment assessments include: cytotoxicity, cytokine expression and gene expression
  • The number of study arms can range from 2 to greater than 10 per patient sample
  • Murine tumors or human cancer cell lines can be studied instead of patient tumor tissue
  • Access and interrogate study results directly in Xsphera’s Cloud Platform

Human Tumor Target Expression

  • Assess proprietary target expression levels on specified patient populations
  • Access and interrogate visualize data directly in Xsphera’s Cloud Platform